McCulloch Kevin

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McCulloch Kevin's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03
PlS Planned sale
78,480 +28.2%
230.12
US$55,709 		78,480 +28.2% 230.12 US$55,709
2026-07-02 2026-07-01
PlS Planned sale
73,081 +16.4%
174.92
US$1,153,368 		73,081 +16.4% 174.92 US$1,153,368
2026-07-01 2026-07-01
PrS Proposed sale
43,929
497.10
US$1,147,329 		43,929 497.10 US$1,147,329
2026-01-09 2026-01-08
PlS Planned sale
15,000 -0.9%
8.00
US$120,000 		15,000 -0.9% 8.00 US$120,000
2026-01-08 2026-01-08
PrS Proposed sale
60,000
7.21
US$432,600 		60,000 7.21 US$432,600
2025-06-16 2025-06-13
B Purchase
25,000 +1.5%
4.38
US$109,475 		25,000 +1.5% 4.38 US$109,475